These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6240072

  • 1. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y, Kasakura H, Matsumoto M.
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract] [Full Text] [Related]

  • 2. The biochemical basis of gangliosidoses.
    Sandhoff K, Conzelmann E.
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract] [Full Text] [Related]

  • 3. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K.
    Clin Chim Acta; 1983 Nov 30; 135(1):89-93. PubMed ID: 6228344
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D, Higashine Y, Matsuoka K, Sakuraba H, Itoh K.
    Clin Chim Acta; 2007 Mar 30; 378(1-2):38-41. PubMed ID: 17196574
    [Abstract] [Full Text] [Related]

  • 5. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A, Holding J, Carey WF.
    Clin Chim Acta; 1982 Apr 23; 120(3):331-40. PubMed ID: 6210469
    [Abstract] [Full Text] [Related]

  • 7. Enzyme replacement in feline GM2 gangliosidosis: catabolic effects of human beta-hexosaminidase A.
    Rattazzi MC, Appel AM, Baker HJ.
    Prog Clin Biol Res; 1982 Apr 23; 94():213-20. PubMed ID: 6214798
    [No Abstract] [Full Text] [Related]

  • 8. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
    Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, Tsuji D, Itoh K, Ishida Y, Suzuki M, Suzuki T, Sakuraba H.
    PLoS One; 2011 Apr 23; 6(12):e29074. PubMed ID: 22205997
    [Abstract] [Full Text] [Related]

  • 9. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA.
    Hum Mol Genet; 1997 Oct 23; 6(11):1879-85. PubMed ID: 9302266
    [Abstract] [Full Text] [Related]

  • 10. Morphology of the gangliosidoses.
    Goebel HH.
    Neuropediatrics; 1984 Sep 23; 15 Suppl():97-106. PubMed ID: 6100800
    [Abstract] [Full Text] [Related]

  • 11. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A, Bourgoin C, Basso L, Emiliani C, Tancini B, Chigorno V, Li YT, Orlacchio A, Poenaru L, Sonnino S, Caillaud C.
    Neurobiol Dis; 2005 Nov 23; 20(2):583-93. PubMed ID: 15953731
    [Abstract] [Full Text] [Related]

  • 12. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A.
    Hoffman LM, Brooks SE, Amsterdam D, Oropello J, Schneck L.
    J Neurosci Res; 1980 Nov 23; 5(5):413-7. PubMed ID: 7441795
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of some minor gangliosides in Tay-Sachs brains.
    Yu RK, Itoh T, Yohe HC, Macala LJ.
    Brain Res; 1983 Sep 19; 275(1):47-52. PubMed ID: 6414648
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS, Krusell A, Krusell J, Lyerla TA, Kolodny EH.
    Am J Hum Genet; 1985 Nov 19; 37(6):1071-82. PubMed ID: 2934978
    [Abstract] [Full Text] [Related]

  • 17. The clinical aspects of adult hexosaminidase deficiencies.
    Federico A, Palmeri S, Malandrini A, Fabrizi G, Mondelli M, Guazzi GC.
    Dev Neurosci; 1991 Nov 19; 13(4-5):280-7. PubMed ID: 1840098
    [Abstract] [Full Text] [Related]

  • 18. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G, Harden A.
    Neuropediatrics; 1984 Sep 19; 15 Suppl():74-84. PubMed ID: 6100798
    [Abstract] [Full Text] [Related]

  • 19. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS, Krasnopol'skaia KD.
    Vopr Med Khim; 1987 Sep 19; 33(4):115-9. PubMed ID: 3116767
    [Abstract] [Full Text] [Related]

  • 20. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R, Rangaswamy GR, Shetty KT.
    Indian J Pediatr; 1995 Sep 19; 62(4):479-83. PubMed ID: 10829909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.